Sonova Holding AG stock (CH0012549785): Inclusion in Euronext Low Carbon 100 Europe index

Sonova Holding AG, a leading provider of hearing care solutions, was included in the Euronext Low Carbon 100 Europe PAB index, as announced on the Euronext live site as of May 2026. This addition underscores the company's progress in low-carbon practices, positioning it alongside peers like Siemens AG and Swisscom AG in a benchmark for sustainable European firms.

The index tracks companies with strong environmental performance. Sonova's inclusion reflects its ESG initiatives, relevant for US investors tracking global medtech exposure via ADRs or international portfolios.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

Sonova Holding AG: core business model

Sonova Holding AG develops, manufactures and distributes hearing instruments and cochlear implants worldwide. The company operates through brands like Phonak, Unitron and Advanced Bionics, serving audiologists and retail channels. In fiscal year 2024/25 (ended March 2025), Sonova reported sales of CHF 3.9 billion, up 8% at constant currency, per its IR site as of May 2025.

Its business model emphasizes innovation in digital hearing aids and connectivity features, capturing over 20% global market share in premium hearing devices. US investors note Sonova's strong North American revenue, around 30% of total, driven by aging demographics.

Main revenue and product drivers for Sonova Holding AG

Hearing instruments account for 85% of revenue, with cochlear implants at 10% and consumer audio at 5%. Key products include Phonak Lumity platform, launched in 2023, featuring AI-driven sound processing. Growth is fueled by reimbursement improvements in the US Medicare market and expansion in emerging regions.

In Q3 2025/26 (October-December 2025), sales rose 10% to CHF 1.0 billion, beating expectations due to strong US demand, according to company reports on its IR page.

Industry trends and competitive position

The global hearing aid market is projected to reach $10 billion by 2028, per Statista data published 2025, driven by OTC devices and tele-audiology post-COVID. Sonova competes with GN Store Nord, Demant and WS Audiology, holding a leadership in wireless tech.

Its ESG focus, including carbon-neutral goals by 2030, aided the Euronext index inclusion, appealing to sustainable US funds tracking European medtech.

Why Sonova Holding AG matters for US investors

Sonova offers US investors indirect exposure to the $7 billion US hearing care market via its OTC partnerships and Phonak brand presence. Listed on SIX Swiss, shares trade OTC in the US (SONV.F), providing diversification amid domestic medtech giants like Stryker (SYK) and Becton Dickinson (BDX).

Conclusion

Sonova Holding AG's addition to the Euronext Low Carbon 100 index highlights its sustainability credentials alongside solid growth in hearing care. With robust US market exposure and innovation pipeline, the company remains a key player. Investors monitor upcoming fiscal 2025/26 results for continued momentum.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.